Market Place
Sourcing Support
All News #Library
Others
ProBioGen Appoints Alfred Merz as CEO
31 Mar 2025 //
CONTRACTPHARMA
ProBioGen, ImmunOs Therapeutics Extend Clinical Mfg. Pact
13 Apr 2023 //
CONTRACT PHARMA
ProBioGen & ImmunOs join hands to deliver innovative therapy for cancer patients
13 Apr 2023 //
INDIAN PHARMA POST
ProBioGen, Boehringer Partner on DirectedLuck Transposase Technology
10 Jan 2023 //
CONTRACTPHARMA
ProBioGen co-develops new Freedom ExpiCHO-S cell line development kit
28 Oct 2022 //
INDIANPHARMAPOST
ProBioGen, Granite Bio Enter Development and Manufacturing Partnership
12 Jul 2022 //
CONTRACTPHARMA
ProBioGen & ValenzaBio Enter Second Service Agreement
14 Jun 2022 //
CONTRACTPHARMA
ProBioGen signs licence agreement with AstraZeneca for GlymaxX technology
14 Feb 2022 //
EXPRESS PHARMA
ProBioGen Makes Innovent as new partner signing license of GlymaxX technology
13 Jan 2022 //
PHARMABIZ
ProBioGen’s GlymaxX Technology Reaches Phase III Development
17 Dec 2021 //
EXPRESSPHARMA
Nobelpharma inks licensing pact for ProBioGen’s vaccine manufacturing platform
14 Aug 2021 //
PHARMABIZ
Nobelpharma Signs License Deal to Use ProBioGen’s Vaccine Production Platform
11 Aug 2021 //
CONTRACT PHARMA
ProBioGen, LAVA enter agreement for cell line development
23 Jun 2021 //
PHARMABIZ
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate
22 Jun 2021 //
CONTRACTPHARMA
AbbVie Licenses ProBioGen’s GlymaxX Technology
22 Jan 2021 //
CONTRACTPHARMA
ImmunOs Uses ProBioGen’s Pathway Modulator Technology
27 Oct 2020 //
CONTRACT PHARMA
ImmunOs Uses ProBioGen’s Pathway Modulator Technology
26 Oct 2020 //
CONTRACTPHARMA
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
22 Oct 2020 //
CONTRACTPHARMA
ImmunOs has pipeline of novel agents in development
25 Feb 2020 //
BIOSPECTRUMASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.